IN8bio, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
13.00
|
|
Average Rating
|
4.50
|
|
# Strong Buys
|
1
|
|
# Buys
|
1
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2023-03-31
|
-0.27
|
0.00
|
0.27
|
100.00%
|
|
2022-12-31
|
-0.31
|
0.00
|
0.31
|
100.00%
|
|
2022-09-30
|
-0.29
|
-0.34
|
-0.05
|
-17.24%
|
|
2022-06-30
|
-0.29
|
-0.38
|
-0.09
|
-31.03%
|
|
2022-03-31
|
-0.33
|
-0.33
|
0.00
|
0.00%
|
|
2021-12-31
|
-0.26
|
-0.21
|
0.05
|
19.23%
|
|
2021-09-30
|
-0.28
|
-0.25
|
0.03
|
10.71%
|
|
2021-06-30
|
-0.40
|
-0.55
|
-0.15
|
-37.50%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-1.05
|
|
2021-12-31
|
-1.83
|
|
2020-12-31
|
-1.65
|
|
2019-12-31
|
-1.71
|
|
2018-12-31
|
-0.16
|